Pilot and Feasibility Program
Pilot and Feasibility Program
批准号:
10252040
负责人:
PAUL W. SANDERS
金额:
$15.03万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2023-07-31
关键词:
Acute Renal Failure with Renal Papillary NecrosisAddressAreaAwardDataDevelopmentDoctor of PhilosophyExtramural ActivitiesExtramural Funding MechanismsFacultyFundingGoalsGrantInstitutionInvestmentsKidneyMissionPaperPeer ReviewPhysiciansPilot ProjectsProductivityPublishingResearchResearch PersonnelResearch ProposalsResearch SupportResourcesScientistSeedsStudy SectionTrainingcareer developmentfield studyinnovationinterestprogramsrecruitresearch and developmentresponsesuccess
中文摘要
项目摘要
UAB-UCSD O‘Brien中心试点和可行性(PAF)赠款计划的主要目标是
为与AKI相关的新的、突出的和创新的研究提案提供种子资金。这些飞行员
基金将为符合条件的调查人员提供一到两年的支持,以及必要的资源
探索由调查人员发起的与AKI相关的项目。
UAB-UCSD O‘Brien中心PAF计划将有三方重点关注,任务1)吸引
初级教员参与AKI相关研究;2)使其他领域的资深研究人员能够探索可行性
在与AKI相关的研究中引入新的创新概念;以及3)吸引具有研究专长的调查人员
核心中心的主题领域将其专业知识应用于与AKI相关的问题。PAF计划已经被
成功地完成了这项任务。有很高的经常性兴趣,平均每年有19份申请
对我们的RFA做出回应。所有的资助申请都被我们的研究组评为非常有价值的,
由我们的内部专家组成。该计划招募了12名内科科学家和11名博士科学家,
包括来自加州大学伯克利分校和加州大学圣地亚哥分校以外的机构的有前途的教师。23名调查人员中有18人获得了资金
这项计划是AKI领域的新成员,约83%的人仍在进行与肾脏相关的研究。这些
调查人员表现出了显著的工作效率,包括Pilot发表的39篇同行评议的论文
在此周期内获得资助的收件人。目前,23名获奖者合计成功率为66.7%
获得随后的外部资金。UAB-UCSD O‘Brien Center PAF计划将继续
利用UAB和UCSD的机构资源(本周期为335,000美元),这将允许
增加我们的试点计划接受者的总投资。将继续每年颁发三至四个奖项
将由该计划支持,其中两个由奥布莱恩中心基金支持,另外1-2个由
机构基金。
UAB-UCSD O‘Brien Center PAF计划的最终目标是提供足够的资源和
对飞行员调查人员进行培训,以进行促进AKI治疗的研究。
英文摘要
Project Summary
The principal objective of the UAB-UCSD O'Brien Center Pilot and Feasibility (PAF) Grants Program is
to provide seed funds for new, outstanding, and innovative research proposals related to AKI. These pilot
funds will provide eligible investigators with one to two years of support along with the resources necessary to
explore investigator-initiated projects related to AKI.
The UAB-UCSD O'Brien Center PAF Program will have a tri-partite focus with a mission 1) to attract
junior faculty to AKI-related research; 2) enable established investigators in other fields to explore the feasibility
of new, innovative concepts in AKI-related research; and 3) entice investigators with research expertise in the
Core Center's thematic areas to apply their expertise to AKI-related questions. The PAF Program has been
successful in this mission. There is a high level of recurring interest, with an average of 19 applications/year in
response to our RFAs. All funded applications were judged to be highly meritorious by our study section, which
consists of our intramural experts. The Program has recruited 12 physician-scientists and 11 Ph.D. scientists,
including promising faculty from institutions outside UAB and UCSD. Eighteen of the 23 investigators funded
by this program were new to the AKI field, and about 83% have remained in kidney-related research. These
investigators have demonstrated significant productivity, including 39 peer-reviewed papers published by pilot
recipients funded during this cycle. At present, collectively the 23 recipients have a 66.7% success rate in
obtaining subsequent extramural funding. The UAB-UCSD O'Brien Center PAF Program will continue to
leverage institutional resources ($335,000 during the present cycle) at both UAB and UCSD, which will permit
an increase in the total investment for our Pilot Program recipients. Three to four awards per year will continue
to be supported by this program, with two supported by O'Brien Center funds and the additional 1-2 from
institutional funds.
The ultimate goal of the UAB-UCSD O'Brien Center PAF program is to provide sufficient resources and
training for pilot investigators to pursue research that advances the treatment of AKI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pre-Clinical Core
-
批准号:10746570
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2023
-
负责人:PAUL W. SANDERS
-
依托单位:
Vascular Mechanisms of Hypertensive Nephropathy
-
批准号:10533780
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:PAUL W. SANDERS
-
依托单位:
Vascular Mechanisms of Hypertensive Nephropathy
-
批准号:10363532
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:10041695
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:10578666
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:10295150
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:9778058
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:8277784
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:8696837
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:8140851
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:PAUL W. SANDERS
-
依托单位:
Low Molecular Weight Protein Nephrotoxicity
-
批准号:8398973
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:PAUL W. SANDERS
-
依托单位:
Mechanisms of Salt-Sensitive Hypertension and Hypertensive Nephrosclerosis
-
批准号:7903735
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2009
-
负责人:PAUL W. SANDERS
-
依托单位:
Core B - Resource for Pre-Clinical Studies of AKI
-
批准号:10252038
-
项目类别:
-
资助金额:$25.44万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
Pilot and Feasibility Program
-
批准号:10456261
-
项目类别:
-
资助金额:$15.03万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
Core B - Resource for Pre-Clinical Studies of AKI
-
批准号:10456259
-
项目类别:
-
资助金额:$25.44万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
Resource for Pre-Clinical Studies of AKI (Animal Models/lmaging/Renal Physiology
-
批准号:8733666
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
Resource for Pre-Clinical Studies of AKI (Animal Models/lmaging/Renal Physiology
-
批准号:9124659
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
Resource for Pre-Clinical Studies of AKI (Animal Models/lmaging/Renal Physiology
-
批准号:8625443
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
Resource for Pre-Clinical Studies of AKI (Animal Models/lmaging/Renal Physiology
-
批准号:8899510
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2008
-
负责人:PAUL W. SANDERS
-
依托单位:
NITRIC OXIDE AND HEREDITARY LOW RENIN HYPERTENSION
-
批准号:2145379
-
项目类别:
-
资助金额:$15.84万
-
财政年份:1992
-
负责人:PAUL W. SANDERS
-
依托单位:
海外基金